$2.90
0.0250.87%
Last update: Aug 14, 2:10 PM
Altimmune Inc Earnings Estimates
ALTNASDAQ
Earnings: Q2 2026 Earnings were released on Wed Aug 12th, before the market open
Conference Call: The most recent conference call started at 8:30 AM, 2 days agoClick to view the webcast
Altimmune Earnings Estimates, EPS & Revenue | NASDAQ:ALT
Altimmune (ALT) is scheduled to report Q3 earnings on November 5, 2026. Analysts estimate EPS of $-0.14 and quarterly revenue of $1.4K.
In the most recent quarter (Q2), Altimmune reported EPS of $-0.12, beating estimates of $-0.13 by 0.08%. Revenue came in at $0, missing the estimate of $1.4K by 1%.
Altimmune has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Altimmune has averaged an EPS surprise of 0.17% and a revenue surprise of 13.84%.
Earnings Date
Nov 5
EPS Estimate
$-0.140
Quarterly Revenue Estimate
$1.4K
Annual Revenue
$31K
as of Jun 30
Altimmune Earnings History
Analyze the earnings history of Altimmune using advanced sorting and filters.
Altimmune (ALT) Earnings Per Share
The chart below shows Altimmune's reported EPS compared to analyst estimates over recent quarters.
Altimmune (ALT) Revenue
The chart below shows Altimmune's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Altimmune (NASDAQ:ALT) reporting earnings?
Altimmune (ALT) is scheduled to report earnings on November 5, 2026. The last reported earnings were for reported on August 12, 2026 for Q2.
What were the latest earnings per share (EPS) for Altimmune (NASDAQ:ALT)?
The Actual EPS was $-0.12, which beat the estimate of $-0.13.
What were Altimmune’s (NASDAQ:ALT) revenues?
The Actual Revenue was $0, which missed the estimate of $1.4K.
